You're reading the free version. Trader adds the live tape and alerts.
Start tracking
APGE Sale Disclosure
Henderson Michael Thomas · SEC Form 4 · Filed Jun 24, 2026
Sale
Calculated transaction value
$10.6M
Henderson Michael Thomas Chief Executive Officer
APGE
Apogee Therapeutics
APGE
Transaction date
Jun 22, 2026
Public filing date
Jun 24, 2026
Filing lag
Filed 2 days later
APGE daily price context
Close on/before transaction
$132.55
Jun 22, 2026
First close after public filing
$132.68
Jun 25, 2026
30-day return after filing
+1.21%
Through Jul 24, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 80,000 shares @ $132.54
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001104659-26-077426
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$10.6M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Apogee Therapeutics, Inc. APGE Current | Sale | Jun 22, 2026 | $10.6M |